henhaobio
Sign in

bioRxivMicrobiologyPreprint

Potent SARS-CoV-2 neutralizing antibodies selected from a human antibody library constructed decades ago

M. Qiang, P. Ma, Y. Li, H. Liu, A. Harding, C. Min, L. Liu, M. Yuan, Q. Ji, P. Tao, X. Shi, Z. Li, F. Wang, Y. Zhang, N. C. Wu, C.-C. D. Lee, X. Zhu, J. Gilbert-Jaramillo, A. Saxena, X. Huang, H. Wang, W. James, R. A. Dwek, I. A. Wilson, G. Yang, R. A. Lerner

PDFDOI

Abstract

Combinatorial antibody libraries not only effectively reduce antibody discovery to a numbers game, but enable documentation of the history of antibody responses in an individual. The SARS-CoV-2 pandemic has prompted a wider application of this technology to meet the public health challenge of pandemic threats in the modern era. Herein, we used a combinatorial human antibody library constructed 20 years before the COVID-19 pandemic to discover three highly potent antibodies that selectively bind SARS-CoV-2 spike protein and neutralize authentic SARS-CoV-2 virus. Compared to neutralizing antibodies from COVID-19 patients with generally low somatic hypermutation (SHM), these antibodies contain over 13-22 SHMs, many of which are involved in specific interactions in crystal structures with SARS-CoV-2 spike RBD. The identification of these somatically mutated antibodies in a pre-pandemic library raises intriguing questions about the origin and evolution of human immune responses to SARS-CoV-2.

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.